NO20053612L - 1,2,4-triaminobenzene derivatives useful for the treatment of central nervous system disorders - Google Patents
1,2,4-triaminobenzene derivatives useful for the treatment of central nervous system disordersInfo
- Publication number
- NO20053612L NO20053612L NO20053612A NO20053612A NO20053612L NO 20053612 L NO20053612 L NO 20053612L NO 20053612 A NO20053612 A NO 20053612A NO 20053612 A NO20053612 A NO 20053612A NO 20053612 L NO20053612 L NO 20053612L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- nervous system
- central nervous
- system disorders
- derivatives useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/28—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/32—Oxygen atoms
Abstract
Den foreliggende oppfinnelse vedrører 1,2,4-triaminobenzenderivater med den generelle formel I eller farmasøytisk akseptable salter derav og anvendelsen derav.The present invention relates to 1,2,4-triaminobenzene derivatives of the general formula I or pharmaceutically acceptable salts thereof and the use thereof.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200202012 | 2002-12-27 | ||
PCT/DK2003/000906 WO2004058739A1 (en) | 2002-12-27 | 2003-12-18 | 1,2,4-triaminobenzene derivatives useful for treating disorders of the central nervous system |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20053612D0 NO20053612D0 (en) | 2005-07-25 |
NO20053612L true NO20053612L (en) | 2005-09-23 |
Family
ID=35295526
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20053612A NO20053612L (en) | 2002-12-27 | 2005-07-25 | 1,2,4-triaminobenzene derivatives useful for the treatment of central nervous system disorders |
Country Status (17)
Country | Link |
---|---|
KR (1) | KR20050089862A (en) |
CN (1) | CN100448867C (en) |
AR (1) | AR042656A1 (en) |
BR (1) | BR0317748A (en) |
CL (1) | CL2003002748A1 (en) |
EA (1) | EA008589B1 (en) |
HK (1) | HK1088317A1 (en) |
IS (1) | IS2649B (en) |
MY (1) | MY139844A (en) |
NO (1) | NO20053612L (en) |
PE (1) | PE20041015A1 (en) |
PL (1) | PL377221A1 (en) |
SI (1) | SI1578740T1 (en) |
TW (1) | TWI325414B (en) |
UA (1) | UA79666C2 (en) |
UY (1) | UY28151A1 (en) |
ZA (1) | ZA200504565B (en) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4200259A1 (en) * | 1992-01-08 | 1993-07-15 | Asta Medica Ag | NEW 1,2,4-TRIAMINOBENZOL DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF |
DE19539861A1 (en) * | 1995-10-26 | 1997-04-30 | Asta Medica Ag | Use of 4-amino-4- (4-fluorobenzylamino) -1-ethoxy-carbonylaminobenzen for the prophylaxis and treatment of the consequences of acute and chronic cerebral low blood circulation and neurodegenerative diseases |
GB9915414D0 (en) * | 1999-07-01 | 1999-09-01 | Glaxo Group Ltd | Medical use |
US6117900A (en) * | 1999-09-27 | 2000-09-12 | Asta Medica Aktiengesellschaft | Use of retigabine for the treatment of neuropathic pain |
US6589986B2 (en) * | 2000-12-20 | 2003-07-08 | Wyeth | Methods of treating anxiety disorders |
-
2003
- 2003-12-18 SI SI200330827T patent/SI1578740T1/en unknown
- 2003-12-18 TW TW092135930A patent/TWI325414B/en not_active IP Right Cessation
- 2003-12-18 EA EA200501053A patent/EA008589B1/en not_active IP Right Cessation
- 2003-12-18 PL PL377221A patent/PL377221A1/en unknown
- 2003-12-18 KR KR1020057012183A patent/KR20050089862A/en not_active Application Discontinuation
- 2003-12-18 UA UAA200507206A patent/UA79666C2/en unknown
- 2003-12-18 BR BR0317748-3A patent/BR0317748A/en not_active IP Right Cessation
- 2003-12-18 CN CNB2003801076953A patent/CN100448867C/en not_active Expired - Fee Related
- 2003-12-22 AR ARP030104782A patent/AR042656A1/en unknown
- 2003-12-24 UY UY28151A patent/UY28151A1/en not_active Application Discontinuation
- 2003-12-24 CL CL200302748A patent/CL2003002748A1/en unknown
- 2003-12-26 MY MYPI20035008A patent/MY139844A/en unknown
-
2004
- 2004-01-05 PE PE2004000037A patent/PE20041015A1/en not_active Application Discontinuation
-
2005
- 2005-05-23 IS IS7856A patent/IS2649B/en unknown
- 2005-06-03 ZA ZA200504565A patent/ZA200504565B/en unknown
- 2005-07-25 NO NO20053612A patent/NO20053612L/en not_active Application Discontinuation
-
2006
- 2006-08-04 HK HK06108672.2A patent/HK1088317A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EA008589B1 (en) | 2007-06-29 |
UA79666C2 (en) | 2007-07-10 |
PE20041015A1 (en) | 2005-01-08 |
BR0317748A (en) | 2005-11-22 |
KR20050089862A (en) | 2005-09-08 |
AR042656A1 (en) | 2005-06-29 |
NO20053612D0 (en) | 2005-07-25 |
SI1578740T1 (en) | 2007-08-31 |
MY139844A (en) | 2009-11-30 |
TW200413280A (en) | 2004-08-01 |
PL377221A1 (en) | 2006-01-23 |
IS2649B (en) | 2010-08-15 |
TWI325414B (en) | 2010-06-01 |
HK1088317A1 (en) | 2006-11-03 |
CN100448867C (en) | 2009-01-07 |
IS7856A (en) | 2005-05-23 |
CN1732162A (en) | 2006-02-08 |
CL2003002748A1 (en) | 2005-04-08 |
UY28151A1 (en) | 2004-07-30 |
ZA200504565B (en) | 2006-08-30 |
EA200501053A1 (en) | 2005-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1106645T1 (en) | 1,2,4 TRIAMINOBENZENE DERIVATIVES USEFUL FOR THE THERAPEUTIC TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM | |
NO20054848L (en) | Substituted p-diaminobenzene derivatives | |
NO20073465L (en) | Benzothiazole derivatives | |
NO20044501L (en) | [1,4] diazenino [6,7,1-IJ] quinoline derivatives such as antipsychotics and antidepressants | |
TNSN05045A1 (en) | Indole or benzimidazole derivatives for modulating ikappab kinase | |
NO20050851L (en) | Caspase Inhibitors and Uses thereof | |
NO20021328L (en) | Pyrazolopyrimidia as therapeutic agents | |
CY1109558T1 (en) | Benzo derivative [D] AZEPINIS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS | |
PT1147110E (en) | PIRAZINE (AZA) -INDOL DERIVATIVES | |
NO20064599L (en) | Substituted morpholine and thiomorpholine derivatives | |
ATE524169T1 (en) | THERAPEUTIC STRATEGIES FOR THE PREVENTION AND TREATMENT OF ALZEHEIMER'S DISEASE | |
NO20052698L (en) | 4 (phenylpiperazinylmethyl) benzamide derivatives and their use in the treatment of pain and gaseous tract disorders. | |
NO20060020L (en) | 3-fluoropiperidines as NMDA / NR2B antagonists | |
ATE402176T1 (en) | PYRROLIDINE AND AZETIDINE COMPOUNDS ALSCCR5 ANTAGONISTS | |
NO20052699L (en) | 4 (phenylpiperazinylmethyl) benzamide derivatives and their use in the treatment of pain and gastrointestinal disorders. | |
NO20062599L (en) | Process for the synthesis of perindopril and pharmaceutically acceptable salts thereof | |
NO20030724L (en) | Use of derivatives of valproic acid amides and 2 valproic acid amides for the therapy or prevention of pain and / or headache disorders | |
FI965021A (en) | Benzimidazole derivatives with dopaminergic effect on central nervous system | |
NO20054721L (en) | Substituted aniline derivatives | |
NO20055758L (en) | Heteroaryl-substituted imidazole derivatives as glutamate receptor antagonists | |
ATE389655T1 (en) | PYRIMIDINE DERIVATIVES | |
FI970469A0 (en) | Benzimidazole derivatives with dopaminergic activity | |
MXPA05009282A (en) | Substituted aniline derivatives. | |
MXPA05004273A (en) | Phenylalkyl and pyridylalkyl piperazine derivatives. | |
NO20060112L (en) | Imidazole Derivatives III |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CREP | Change of representative |
Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104 |
|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |